## BACKGROUND. Androgen deprivation is often used for the treatment of patients with prostate cancer. Androgen deprivation can be achieved by surgical castration or medical castration, with or without using an antiandrogen. Each of these treatments may be used alone, or an antiandrogen may be used
Characterization of choline uptake in prostate cancer cells following bicalutamide and docetaxel treatment
✍ Scribed by Sebastian A. Müller; Korbinian Holzapfel; Christof Seidl; Uwe Treiber; Bernd J. Krause; Reingard Senekowitsch-Schmidtke
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 230 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
BACKGROUND. Bicalutamide (Casodex) is a new nonsteroidal antiandrogen developed for use in patients with prostate cancer. The efficacy and tolerability of bicalutamide as monotherapy and as combination therapy for patients with advanced prostate cancer have been evaluated in randomized clinical tria
## Abstract Tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) is a promising cancer therapeutic agent because of its tumor selectivity. TRAIL is known to induce apoptosis in cancer cells but spare most normal cells. In this study, we examined whether treatment of docetaxel (DTX) can e